Page last updated: 2024-08-21

thiazolidines and Hematologic Malignancies

thiazolidines has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, LS; Cortes, J; de Bono, J; Dean, E; DeAngelo, DJ; Gandhi, V; Godin, R; Kantarjian, H; Keating, K; Lorente, D; McEachern, K; Minden, M; Pease, JE; Tamura, K; Uy, GL; Vishwanathan, K	1

Trials

1 trial(s) available for thiazolidines and Hematologic Malignancies

Article	Year
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. British journal of cancer, 2018, Volume: 118, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Biphenyl Compounds; Cytochrome P-450 CYP3A; Female; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Thiazolidines; Up-Regulation; Young Adult	2018

Article

Year

Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers.

British journal of cancer, 2018, Volume: 118, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Biphenyl Compounds; Cytochrome P-450 CYP3A; Female; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Thiazolidines; Up-Regulation; Young Adult

2018